Editorial: is age just a number when it comes to treatment of inflammatory bowel disease?

Aliment Pharmacol Ther. 2020 Nov;52(10):1615-1616. doi: 10.1111/apt.16098.

Authors

Christopher Ma^{1

2}, Siddharth Singh³, Joan Heatherington¹, Remo Panaccione¹

Affiliations

¹ Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Calgary, AB, Canada.
² Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.
³ Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA.

PMID: 33085983
DOI: 10.1111/apt.16098

No abstract available

Publication types

Editorial
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Cohort Studies
Comorbidity
Humans
Inflammatory Bowel Diseases* / drug therapy
Prospective Studies
Ustekinumab*

Substances

Antibodies, Monoclonal, Humanized
vedolizumab
Ustekinumab